153 related articles for article (PubMed ID: 29633730)
1. An uncommon case of chronic myeloid leukemia with variant cytogenetic.
Abdullah MA; Amer A; Nawaz Z; Abdullah AS; Al-Sabbagh A; Kohla S; Nashwan AJ; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):28-32. PubMed ID: 29633730
[TBL] [Abstract][Full Text] [Related]
2. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
[TBL] [Abstract][Full Text] [Related]
3. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib.
Janjetovic S; Asemissen AM; Dicker F; Binder M; Dierlamm J; Bokemeyer C; Schafhausen P
Tumori; 2019 Dec; 105(6):NP8-NP11. PubMed ID: 30935343
[TBL] [Abstract][Full Text] [Related]
4. Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.
Vigna E; Martino B; Bacci F; Recchia AG; Mendicino F; Morelli R; Mauro FR; Musolino C; Greco R; Lucia E; Sabattini E; Morabito F; Gentile M
Chemotherapy; 2017; 62(6):350-352. PubMed ID: 28743118
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.
Wang Z; Zen W; Meng F; Xin X; Luo L; Sun H; Zhou J; Huang L
Int J Clin Exp Pathol; 2015; 8(10):13707-10. PubMed ID: 26722598
[TBL] [Abstract][Full Text] [Related]
6. Gelatinous bone marrow transformation and emergence of clonal Philadelphia-negative cytogenetic abnormalities with excess blasts in a patient with chronic myeloid leukemia treated with dasatinib.
Hermel DJ; Nael A; Lu YT; Kim J; Brynes RK; Vergara-Lluri M; Akhtari M
Anticancer Drugs; 2019 Apr; 30(4):416-421. PubMed ID: 30875349
[TBL] [Abstract][Full Text] [Related]
7. Achievement of a complete cytogenetic response with hydroxyurea in a patient with chronic myelogenous leukemia.
Tanaka M; Yamazaki Y; Kondo E; Hattori M; Tsushita K; Utsumi M
Leuk Res; 1997 May; 21(5):465-8. PubMed ID: 9225076
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
9. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
[TBL] [Abstract][Full Text] [Related]
10. Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridization.
Martín-Subero JI; Lahortiga I; Gómez E; Ferreira C; Larrayoz MJ; Odero MD; García-Delgado M; Novo FJ; Giraldo P; Calasanz MJ
Cancer Genet Cytogenet; 2001 Mar; 125(2):167-70. PubMed ID: 11369063
[TBL] [Abstract][Full Text] [Related]
11. Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.
Albano F; Anelli L; Zagaria A; Coccaro N; Casieri P; Rossi AR; Vicari L; Liso V; Rocchi M; Specchia G
Mol Cancer; 2010 May; 9():120. PubMed ID: 20500819
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
[TBL] [Abstract][Full Text] [Related]
13. Novel variant Ph translocation t(9;22;11)(q34;q11.2;p15)inv(9)(p13q34) in chronic myeloid leukemia involving a one-step mechanism.
Belli C; Alú MF; Alfonso G; Bianchini M; Larripa I
Cytogenet Genome Res; 2011; 132(4):304-8. PubMed ID: 21212648
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a complex translocation [t(4;9;22)(p16;q34;q11)] in chronic myelogenous leukemia by fluorescence in situ hybridization technique.
Gudi R; Elizalde A; Gogineni SK; Macera MJ; Badillo A; Verma RS
Cancer Genet Cytogenet; 1996 Sep; 90(2):142-5. PubMed ID: 8830724
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report.
Oñate G; Blanco ML; Pratcorona M
Med Clin (Barc); 2019 May; 152(10):419-420. PubMed ID: 30392698
[No Abstract] [Full Text] [Related]
17. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
18. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive.
Yehuda O; Abeliovich D; Ben-Neriah S; Sverdlin I; Cohen R; Varadi G; Orr R; Ashkenazi YJ; Heyd J; Lugassy G; Ben Yehuda D
Cancer Genet Cytogenet; 1999 Oct; 114(2):100-7. PubMed ID: 10549264
[TBL] [Abstract][Full Text] [Related]
20. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
Kokate P; Dalvi R; Mandava S
J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
